Meningitis Research Foundation presents our biannual international conference - Meningitis and Septicaemia in Adults and Children

Full details of the two day programme are available to view below including abstracts from all presenters. A full copy of the conference programme is available to download here.

Where permission has been given presentations are now available to download.

Day one - 11th November 2009

Burden of meningitis, prevention of pneumococcal disease, issues in prevention

GlaxoSmithKline satellite breakfast session

8:30 GSK satellite breakfast session
GSK's commitment: past, present and future - Download the presentation
Synflorix: a new pneumococcal conjugate vaccine. - Download the presentation

Session 1 - Counting the cost of meningitis and septicaemia

Chair: Professor Robert Heyderman
Malawi-Liverpool-Wellcome Trust Research Programme 
9:40 The personal costs of meningitis
Norman Pace, Patron, Meningitis Research Foundation, UK 
9:55 Socio/psychological/cognitive sequelae and follow-up care
Dr Simon Nadel, St Mary's Hospital, Imperial College London, UK 
Download the presentation
10:15 Orthopaedic sequelae of meningococcal disease and their management
Mr Fergal Monsell, Bristol Royal Hospital for Children, UK  

10:35 Hearing loss after meningitis: assessment and management
Prof Gerard O'Donoghue, Queen's Medical Centre, Nottingham, UK 
Download the presentation
10:55 Coffee, Exhibition and Posters 

Session 2 - The science and policy of prevention

Chair: Dr Mary Ramsay
Health Protection Agency, Centre for Infections, London
11:25 Setting international immunisation policy and the role of SAGE
Prof David Salisbury CB, Department of Health, London,UK
Download the presentation 
11:50 Best use of conjugate vaccines: waning of infant protection from accelerated schedules; herd immunity; implications for developing countries using EPI schedules?
Dr Caroline Trotter, University of Bristol, UK
Download the presentation 
12:15 Recruitment of Factor H by Neisseria meningitidis and Streptococcus pneumoniae: immune evasion and vaccines
Prof Christoph Tang, Imperial College London, UK
Download the presentation
12:40 Lunch, Exhibition and Posters 

Wyeth Vaccines satellite session

13:30 Wyeth Satellite Session
A debate between Professor Adam Finn (for) and Professor Andrew Pollard (against), chaired by Professor David Goldblatt.
Polysaccharide-conjugate vaccines offer at best a partial and temporary solution to the problem of pneumococcal disease and available resources should be diverted from deployment of such vaccines and invested instead in development and implementation of protein antigen vaccines without delay

Session 3 - Issues in prevention of pneumococcal disease

Chair: Professor Adam Finn
University of Bristol 
14:20 Changes in pneumococcal serotypes in the UK before and after the introduction of PCV7
Dr Robert George, HPA Centre for Infections, London, UK 
14:45 Applying modelling to understanding pneumococcal disease patterns in the UK: replacement and emergent serotypes
Prof John Edmunds, London School of Hygiene and Tropical Medicine
Download the presentation
15:10 Prospects for preventing invasive pneumococcal disease with conjugate vaccines beyond PCV7, including evidence for use in a 2 + 1 immunisation schedule.
Dr Bernard Fritzell, Wyeth Vaccines Research, Paris, France
Dr Lode Schuerman, GlaxoSmithKline Biologicals, Rixensart, Belgium
Download the presentation 
15:40 Tea, Exhibition and Posters 

Session 4 - Future prevention of meningitis in developing countries

Chair: Professor Brian Greenwood
London School of Hygiene and Tropical Medicine 
16:00 Progress on pneumococcal protein vaccines
Dr Mark Alderson, PATH, Seattle, USA
Download the presentation 
16:30 Impact of PneumoADIP: progress on uptake of pneumococcal vaccines in developing countries
Dr Orin Levine, PneumoADIP, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
Download the presentation 
17:00 Impact and challenges of the Hib initiative - understanding and communicating burden of disease
Prof Kim Mulholland, London School of Hygiene and Tropical Medicine, UK
Download the presentation
17:30 Wine reception, Exhibition and Posters 

Day two - 12th November 2009

Treatment of meningitis and septicaemia, prevention of meningococcal disease

Novartis Vaccines satellite breakfast session

8:00 Registration and coffee
08:20 Novartis satellite breakfast session
New approaches to Meningococcal prevention.

Session 1 - Current Issues in treatment

Chair: Professor Nigel Klien
Great Ormond Street Children's Hospital and Institute of Child Health
9:20 NICE guideline on management of meningococcal disease and bacterial meningitis in children
Prof Andrew Pollard, University of Oxford, UK
9:45 Management of neonatal meningitis
Dr Paul Heath, St George's, University of London, UK
Download the presentation
10:10 What happens in childhood sepsis in the UK now? PICS sepsis audit
Dr David Inwald, St Mary's Hospital, Imperial College London, UK

Download the presentation
10:35 The microcirculation in meningococcal septicaemia
Dr Fauzia Paize, Institute of Child Health, University of Liverpool, UK
Download the presentation
10:55 Coffee, exhibition and posters

Session 2 - Management of sepsis and meningitis

Session 3 - Prevention of meningococcal disease

Chair: Professor David Lalloo
Liverpool School of Tropical Medicine
Award for best poster, kindly donated by Wyeth Vaccines
13:50 Meningitis Vaccine Project - update on trial results
Dr Marc LaForce, Meningitis Vaccine Project, PATH / WHO, Ferney-Voltaire, France
Download the presentation
14:20 Evidence for public health management of invasive meningococcal disease
Dr James Stuart, Independent consultant epidemiologist
Download the presentation
14:45 Global Prospects for prevention of MenACWY, including the US experience
Dr Amanda Cohn, Centers for Disease Control and Prevention, Atlanta, USA
Download the presentation 
15:15 Tea, exhibition and posters 

Session 4 - Future prevention of meningococcal B

Chairs: Professor Andrew Pollard, University of Oxford and Professor Ray Borrow, HPA Manchester
15:35 Candidate MenB vaccines in clinical trials; coverage; implementation issues; further research strategies for more broadly protective MenB vaccines

Overview, data presentation and debate of issues by a panel:
17:05  Close

MRF Funded Research

Since 1989 MRF has funded 140 research grants at a cost of over £17/€21m.View the projects using our interactive research map

Read more
Tools for Health Professionals